Biotechnology – Advanced Study Notes
(Medical Lab Technology – Biology – MIT‑level)
1. Introduction
| Term | Definition | Core Idea |
|---|---|---|
| Biotechnology | The application of biological systems or organisms to develop or modify products and processes for specific uses. | Leverages molecular and cellular mechanisms to engineer desired traits. |
| Genetic Engineering | Direct manipulation of an organism's genome using recombinant DNA techniques. | Enables precise, heritable changes. |
| Synthetic Biology | Design‑build‑test cycles for constructing novel biological parts, devices, and systems. | Blends engineering principles with biology. |
| Bioprocessing | Production of valuable biomolecules (proteins, nucleic acids, metabolites) at scale. | Requires process optimization (upstream/downstream). |
2. First Principles
2.1 Molecular Basis of Life
- DNA: Double‑helix, Watson–Crick base pairing, replication fidelity governed by DNA polymerases and proofreading.
- RNA: Single‑stranded, central to gene expression (mRNA, tRNA, rRNA).
- Proteins: Polypeptide chains folded by the Anfinsen hypothesis; structure dictates function.
2.2 Gene Expression Regulation
- Transcription: RNA polymerase holoenzyme; promoter recognition (σ factors in bacteria, TATA box in eukaryotes).
- Post‑transcriptional: RNA splicing, editing, stability.
- Translation: Ribosome, codon‑anticodon pairing, elongation factors.
- Post‑translational: PTMs (phosphorylation, glycosylation), protein‑protein interactions.
2.3 DNA Manipulation Tools
- Restriction Enzymes: Sequence‑specific endonucleases; produce sticky or blunt ends.
- Ligases: DNA ligase (ATP‑dependent) covalently joins nicks.
- Polymerases: PCR (Taq), high‑fidelity (Pfu), isothermal amplification (LAMP, RPA).
- CRISPR‑Cas Systems: RNA‑guided nucleases (Cas9, Cas12, Cas13); programmable DNA/RNA editing.
3. Core Techniques in Biotechnology
| Technique | Principle | Applications | Key Considerations |
|---|---|---|---|
| Cloning | Insertion of DNA fragment into plasmid/virus vector | Gene expression, recombinant protein production | Vector copy number, promoter strength, host strain |
| Transformation | Uptake of foreign DNA by cells | Bacterial, yeast, mammalian transfection | Electroporation vs chemical; selection markers |
| Transfection | Delivery of plasmid DNA into eukaryotic cells | Gene therapy, vaccine development | Efficiency, cytotoxicity, integration vs episomal |
| Protein Expression | Production of recombinant protein in host | Therapeutic proteins, enzymes | Codon optimization, post‑translational modifications |
| Purification | Isolation of target protein | Biopharmaceutical production | Affinity tags, chromatography (IMAC, ion exchange) |
4. Advanced Topics
4.1 Gene Editing – CRISPR/Cas Systems
- Components: Cas nuclease, guide RNA (gRNA), PAM sequence.
- Mechanism: Double‑strand break → Non‑homologous end joining (NHEJ) or Homology‑Directed Repair (HDR).
- Ethical Edge Cases: Off‑target effects, germline editing, mosaicism.
4.2 Synthetic Biology – Design Principles
- Modularity: Parts (promoters, RBS, coding sequences) treated as Lego bricks.
- Standardization: Biobricks, Registry of Standard Biological Parts.
- Modeling: Systems biology (ODE, stochastic simulations) to predict behavior.
4.3 Metabolic Engineering
- Flux Balance Analysis (FBA): Constraint‑based modeling to predict metabolic fluxes.
- Rewiring Pathways: Knockout, overexpress, introduce heterologous enzymes.
- Industrial Production: Biofuels, antibiotics, specialty chemicals.
4.4 Bioprocess Engineering
- Upstream: Cell culture, media optimization, bioreactor design.
- Downstream: Harvesting, clarification, chromatography, formulation.
- Scale‑up Challenges: Shear stress, oxygen transfer, heat removal.
5. Edge Cases & Common Pitfalls
| Scenario | Problem | Mitigation |
|---|---|---|
| Promoter leakage | Unintended expression in absence of inducer | Use tight regulation systems (lacI, tetR). |
| Plasmid instability | Loss of copy number over generations | Incorporate partitioning systems (par loci). |
| Protein aggregation | Insoluble inclusion bodies | Lower temperature, co‑expression of chaperones. |
| Off‑target CRISPR editing | Unintended mutations | Use high‑fidelity Cas variants, truncated gRNAs. |
| Batch variability | Inconsistent yields | Implement process analytical technology (PAT). |
6. Mathematical Foundations
6.1 PCR Efficiency
Let ( N_t ) be the number of DNA molecules after ( t ) cycles.
( N_t = N_0 (1+E)^t )
where ( E ) is the efficiency (0–1).
Edge case: ( E < 0.9 ) leads to exponential plateau; requires optimization of primer design and polymerase.
6.2 Gene Expression Modelling
For a single gene:
( \frac{d[mRNA]}{dt} = k_{\text{transcription}} - \gamma_{\text{mRNA}}[mRNA] )
( \frac{d[Protein]}{dt} = k_{\text{translation}}[mRNA] - \gamma_{\text{protein}}[Protein] )
Steady‑state solutions provide insight into protein abundance.
7. Challenging Problem
Scenario
You are tasked with engineering E. coli to produce a therapeutic glycoprotein that requires complex N‑linked glycosylation. Native E. coli lacks the machinery.
Questions
-
Design Strategy
- Outline a step‑by‑step plan to introduce eukaryotic glycosylation pathways into E. coli.
- Specify the essential genes, promoters, and host strain modifications.
-
Quantitative Analysis
- Given the following parameters:
- Glycosyltransferase expression level (= 5 \times 10^7 ) molecules/cell.
- Substrate availability: UDP‑GlcNAc (= 1
- Given the following parameters: